Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: 68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating 68Ga-RM2 PET/CT for detecting regional nodal and distant metastases in intermediate/high-risk prostate cancer; resu…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: VMAT for Dominant Intraprostatic Lesion [NA]
Clinical trial update reporting completion of a study evaluating VMAT for a dominant intraprostatic lesion in prostate cancer, with results …
-
CLINICAL_TRIALS trial_result · 2023-05-22Clinical Trial Update: Muscadine Plus (MPX) In Men With Prostate Cancer [Phase 3]
Phase 3 clinical trial of Muscadine Plus (MPX) in men with prostate cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 [Phase 2]
Phase II study evaluating an adenovirus PSA vaccine in men with recurrent prostate cancer after local therapy has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating LHRH analogue therapy in combination with enzalutamide or bicalutamide for hormone-sensitive prostate ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution [NA]
Clinical trial update on CyberKnife radiosurgery for organ-confined prostate cancer with homogeneous dose distribution; study completed and …
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry [NA]
Clinical trial update for CyberKnife radiosurgery in low and intermediate risk prostate cancer; results regarding emulating HDR brachytherap…
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating PSMA-PET to guide biopsy and treatment decisions in primary prostate cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2023-05-08Clinical Trial Update: Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial of an mRNA-transfected dendritic cell vaccine for androgen-resistant metastatic prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Enzalutamide + External Beam Rt For Prostate [Phase 2]
Phase 2 trial evaluating enzalutamide combined with external beam radiotherapy in intermediate-risk prostate cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding [Phase 2]
Phase 2 trial update evaluating a prostate immobilization device used during radiation to reduce rectal bleeding in prostate cancer patients…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]
Clinical trial update examining Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT imaging in the same group of prostate cancer patients across Phase 2…
-
CLINICAL_TRIALS trial_result · 2023-05-01Clinical Trial Update: Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for trametinib in progressive metastatic hormone-resistant prostate cancer; currently active but not recruitin…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer [Phase 2]
Phase II study of an adenovirus/PSA vaccine in men with hormone-refractory prostate cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) [Phase 2]
Phase 2 trial evaluating Best Systemic Therapy (BST) with definitive treatment (radiation or surgery) in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating orteronel (TAK-700) in combination with hormone therapy and radiation therapy for high-risk prostate cance…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: SRT Versus SRT+ADT in Prostate Cancer [Phase 3]
A Phase 3 clinical trial comparing SRT alone versus SRT plus androgen deprivation therapy in prostate cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy [Phase 3]
A Phase 3 clinical trial update examines tranexamic acid effects in patients undergoing laparoscopic radical prostatectomy for prostate canc…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy [Phase 2, Phase 3]
A clinical trial update evaluating systemic therapy for advancing or metastatic prostate cancer across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial investigating 68Ga-RM2 PET/MRI in biochemically recurrent prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study [Phase 2]
A Phase II single-center study evaluating PET/MR for restaging in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Non-randomized Phase 2 trial assessing pain efficacy of Radium-223 in symptomatic metastatic castration-resistant prostate cancer has comple…
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating pentoxifylline, atorvastatin, and vitamin E for erectile dysfunction after prostate cancer radiation therapy; study…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance [Phase 2]
Phase 2 clinical trial investigating a carbohydrate-restricted diet intervention for men with prostate cancer on active surveillance has com…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression [Phase 2, Phase 3]
A study evaluating the effectiveness of aspirin and/or vitamin D3 in preventing progression of prostate cancer has completed phase 2 and pha…